Recombinant LRP 5/6 抗体
The Human 单克隆 anti-LRP 5/6 antibody (Clone Heldy-1-4) (ABIN5564227) specifically detects LRP 5/6 in FACS.
The antibody is reactive with 人 和 小鼠 samples.
产品编号 ABIN5564227
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant LRP 5/6 抗体 (ABIN5564227)
抗原
LRP 5/6
抗体类型
Recombinant Antibody
适用
人, 小鼠
宿主
Human
克隆类型
单克隆
应用范围
Flow Cytometry (FACS)
克隆位点
Heldy-1-4
-
-
特异性
- Recognizes human and mouse LRP5 & LRP6.
-
交叉反应
- 人, 小鼠
-
纯度
- >95 % (SDS-PAGE)
-
免疫原
- Recombinant mouse LRP6.
-
亚型
- IgG2
-
-
-
说明
-
anti-LRP5/6 (human), mAb (rec.) (Heldy-1-4) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- In PBS containing 10 % glycerol.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. -
有效期
- 12 months
-
-
- LRP 5/6
-
别名
- LRP5/6
-
背景
- Wnt/beta-catenin signaling acts as a regulator of tissue development and homeostasis. Wnt ligands bind to a member of the Frizzled family of seven-transmembrane proteins and to either highly homologous low-density lipoprotein related receptors 5 (LRP5) or LRP6. Low-density lipoprotein receptor-related protein 6 (LRP6) is a member of the low-density lipoprotein receptor (LDLR) family. LRP5 and LRP6 are expressed in most human tissues and is composed of three distinctive cell-surface protein domains, including (1) LDL receptor (LDLR) type A repeats, (2) an epidermal growth factor (EGF)-like domain, and (3) a YWTD (Tyr-Trp-Thr-Asp)-type beta propeller domain. LRP6 is inhibited by the Dickkopf protein Dkk1 bound to their partners Kremen. Sclerotin also acts as an inhibitor of LRP5/6 through LRP4. LRP6 is involved in cell differentiation, proliferation and migration during embryonic development and in the pathogenesis of different cancer types. LRP6 plays a major role in metabolic regulation, specifically in the nutrient-sensing pathway. Patients carrying an LRP6 mutation exhibit high serum LDL cholesterol and triglycerides, hypertension, high fasting blood glucose levels, a prevalence of diabetes and low bone density. LRP6 mutations have also been associated with diseases such as Alzheimer's and degenerative joint diseases. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density and plays a role in osteoporosis. LRP5 is aso involved in vitreoretinopathy.
抗原
-
You are here:
